0:00
15:30
Bempedoic Acid aka Nexletol has a new trial in NEJM that shows MACE reduction in very high risk patients (mostly secondary but some primary prevention). NNT? NNH? Other trials on Bempedoic acid? Tune in and find out.
More episodes from "Primary Care Pod"
Don't miss an episode of “Primary Care Pod” and subscribe to it in the GetPodcast app.